Skip to main content
. 2017 Mar 27;37(2):BSR20170047. doi: 10.1042/BSR20170047

Table 2.

Characteristics of MPs in healthy subjects and patients with AMI or CAD

Characteristics AMI CAD Healthy controls P-value
CD31+/CD42b− MPs 12.5 ± 5.7 0.08 ± 0.07 0.04 ± 0.03 0.0003*
CD31+/CD42b+ MPs 3.4 ± 2.4 3.9 ± 1.8 3.8 ± 2.1 0.18
CD31−/CD42b− MPS 79 ± 8.9 82 ± 11.9 84 ± 10.6 0.37

Comparison was conducted between SCAD and AMI group and P-value was shown, * a value of P<0.05 was considered with significant difference.